Keywords: Salix Pharma, Oceana Theapeutics, M&D, Third-quarter 2011 financial results

Salix Pharma to buy Oceana for $300 million; posts 3rd-qtr profit

Article | 09 November 2011

Print This

With the aim of improving its innovate products franchise, US drugmaker Salix Pharmaceuticals (Nasdaq: SLXP) has entered into an agreement ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in